AstraZeneca Seeks To Shield Seroquel Sales Rep Notes, Study Reports In Pending Injury Cases
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca says internal company information should not be released before personal injury cases go to trial.